Your patient needs antithrombotic drugs, 7. Averting the risk of stroke: with whom and how?
Stiefelhagen, P.
MMW Fortschritte der Medizin 155(13): 24
2013
ISSN/ISBN: 1438-3276 PMID: 23964495 Document Number: 665809
Document emailed within 1 workday
Related Documents
Alvarez-Sabín, J. 2001: Hemorrhagic stroke antithrombotic drugs Revista de Neurologia 32(9): 848-850Poungvarin, N.; Ketsa-Ard, K. 1989: Low dose aspirin and its antithrombotic effect in ischaemic stroke patient Journal of the Medical Association of Thailand 72(8): 421-426
Yaghy, M.; Murin, J.; Pernicky, M.; Pekarovicova, Z.; Mikes, P. 2008: Antithrombotic treatment in patients with atrial fibrillation as a risk factor of stroke Bratislavske Lekarske Listy 109(3): 133-140
Stiefelhagen, P. 2013: Your patient needs antithrombotic drugs, 8. Which thrombosis prevention for tumor patients? MMW Fortschritte der Medizin 155(18): 26
Zhunussov, Y.; Taizhanova, D.; Abdullabekova, R.; Bitz, U.; Visternichan, O. 2016: Optimum Application of Modern Antithrombotic Drugs among Patients with the Acute Coronary Syndrome with the Risk of Stricture Formation of Coronary Arteries Georgian Medical News 251: 40-45
Koczorek, M. 2001: Is your patient at risk for stroke? Cutting the risk in half! MMW Fortschritte der Medizin 143(35-36): 4-8
DiMinno, G.; Silver, M.J. 1983: Mouse antithrombotic assay: a simple method for the evaluation of antithrombotic agents in vivo. Potentiation of antithrombotic activity by ethyl alcohol Journal of Pharmacology and Experimental Therapeutics 225(1): 57-60
Uchiyama, S. 2006: Antithrombotic therapy in acute ischemic stroke Rinsho Shinkeigaku 46(11): 844-846
Ni, M.J.; Fu, L.Ping.; Chen, X.Ling.; Hu, X.Yuan.; Wheeler, K. 2012: Net financial benefits of averting HIV infections among people who inject drugs in Urumqi, Xinjiang, Peoples Republic of China (2005-2010) BMC public health 12: 572
Hanchaiphiboolkul, S.; Poungvarin, N.; Nidhinandana, S.; Suwanwela, N.C.; Puthkhao, P.; Towanabut, S.; Tantirittisak, T.; Suwantamee, J.; Samsen, M. 2011: Prevalence of stroke and stroke risk factors in Thailand: Thai Epidemiologic Stroke (TES) Study Journal of the Medical Association of Thailand 94(4): 427-436
Chen, S.-H.; Lee, H.-C.; Chang, K.-C.; Hung, J.-W.; Chen, H.-M.; Wu, C.-Y.; Yang, C.-L.; Huang, Y.-C.; Wang, H.-H. 2019: Low Persistence of Antithrombotic Agents is Associated with Poor Outcomes after First-ever Acute Ischemic Stroke Acta Neurologica Taiwanica 28(4): 95-118
Po, H.L.; Lin, Y-Ju.; Hseuh, I-Hung. 2009: The prescribing patterns of antithrombotic agents for prevention of recurrent ischemic stroke Acta Neurologica Taiwanica 18(2): 98-103
Giordano, P.; Sabato, V.; Schettini, F.; De Mattia, D.; Iolascon, A. 1997: Resistance to activated protein C as a risk factor of stroke in a thalassemic patient Haematologica 82(6): 698-700
Tsuzuki, N. 2002: Clinical characteristics and antithrombotic therapy for stroke prevention in patients with atrial fibrillation Hokkaido Journal of Medical Science 77(6): 563-570
Gudkova, V.V.; Stakhovskaia, L.V.; Shanina, T.V.; Meshkova, K.S.; Shekhovtsova, K.V. 2011: The antithrombotic treatment in the secondary prevention of ischemic stroke: strategy and tactic issues Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 111(11 Pt 1): 87-94
Ilić, Mš.; Kikelj, D.; Ilaš, J. 2011: Multitarget antithrombotic drugs Current Topics in Medicinal Chemistry 11(22): 2834-2848
Hladovec, J. 1972: Antithrombotic drugs and experimental thrombosis Cor et Vasa 20(2): 135-141
Hidden-Lucet, F.ço. 2002: Antithrombotic drugs in atrial fibrillation La Revue du Praticien 52(12): 1324-1328
Tufano, A.; Cerbone, A.M.; Di Minno, G. 2002: The use of antithrombotic drugs in older people Minerva Medica 93(1): 13-26
Busch, M.; Masuhr, F. 2004: Thromboprophylaxis and early antithrombotic therapy in patients with acute ischemic stroke and cerebral venous and sinus thrombosis European Journal of Medical Research 9(4): 199-206